Page 4 - SLIDES
P. 4

VESPER V05











             • GETUG/AFU

             • Phase III trial (n=493), 28

                French centres


             • Accrual 2013-2018


             • Perioperative chemo RCT but

                89% NAC


             • Neoadjuvant chemo trial:
                ddMVAC vs GC
   1   2   3   4   5   6   7   8   9